Clinical Trial Update: The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adding TCM-700C to standard therapy for hepatitis C genotype 1 was withdrawn from the study. No results were reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TCM-700C

Snippet

Sponsor: TCM Biotech International Corp. | Conditions: Chronic Hepatitis C | Phase 3 | Status: WITHDRAWN